These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35017743)

  • 41. New data emerging on outcomes for patients with COVID-19 and rheumatic diseases.
    Onuora S
    Nat Rev Rheumatol; 2020 Aug; 16(8):407. PubMed ID: 32620941
    [No Abstract]   [Full Text] [Related]  

  • 42. The psychological impact of the COVID-19 pandemic on Dutch people with and without an inflammatory rheumatic disease.
    Koppert TY; Jacobs JWG; Geenen R
    Rheumatology (Oxford); 2021 Aug; 60(8):3709-3715. PubMed ID: 33313870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [INTERNATIONAL COOPERATION IN PEDIATRIC RHEUMATOLOGY IN THE CORONA ERA].
    Uziel Y
    Harefuah; 2021 May; 160(5):276-278. PubMed ID: 34028217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rheumatology and COVID-19 at 1 year: facing the unknowns.
    Calabrese L; Winthrop KL
    Ann Rheum Dis; 2021 Jun; 80(6):679-681. PubMed ID: 33658236
    [No Abstract]   [Full Text] [Related]  

  • 45. Reply.
    Mikuls TR; Fraenkel L; Gravallese E; Johnson SR; Turner A; Saag KG
    Arthritis Rheumatol; 2021 Mar; 73(3):548-549. PubMed ID: 33142024
    [No Abstract]   [Full Text] [Related]  

  • 46. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience.
    Aydın F; Kurt T; Sezer M; Tekgöz N; Ekici Tekin Z; Kanık Yüksek S; Çelikel Acar B
    Int J Clin Pract; 2021 Jul; 75(7):e14030. PubMed ID: 34233400
    [No Abstract]   [Full Text] [Related]  

  • 48. Impact of COVID-19 pandemic on management of autoimmune and inflammatory diseases in Morocco.
    Wafa A; Hicham H; Hajar K; Mouna M; Zoubida MT; Mohamed A
    Pan Afr Med J; 2020; 37():240. PubMed ID: 33552358
    [No Abstract]   [Full Text] [Related]  

  • 49. [CME Rheumatology 23: Rheumatoid Arthritis Following COVID-19/SARS-CoV-2 Infection].
    Tamborrini G; Micheroli R
    Praxis (Bern 1994); 2021 Apr; 110(6):293-297. PubMed ID: 33906448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 test patterns in Danish patients with inflammatory rheumatic diseases during the COVID-19 pandemic.
    Alzubaidi A; Cordtz R; Westermann R; Soussi BG; Lauridsen KB; Kristensen S; Dreyer L
    Scand J Rheumatol; 2023 May; 52(3):321-323. PubMed ID: 36632996
    [No Abstract]   [Full Text] [Related]  

  • 51. Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands.
    Bos WH; van Tubergen A; Vonkeman HE
    Rheumatol Int; 2021 Mar; 41(3):565-573. PubMed ID: 33449162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [CME Rheumatology 23/Answers: Rheumatoid Arthritis Following COVID-19/SARS-CoV-2 Infection].
    Tamborrini G; Micheroli R
    Praxis (Bern 1994); 2021; 110(7):375-376. PubMed ID: 34019443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic.
    Fragoulis GE; Evangelatos G; Arida A; Bournia VK; Fragiadaki K; Karamanakos A; Kravvariti E; Laskari K; Panopoulos S; Pappa M; Tektonidou MG; Sfikakis PP
    Ann Rheum Dis; 2021 Apr; 80(4):e60. PubMed ID: 32475830
    [No Abstract]   [Full Text] [Related]  

  • 54. A bibliometric analysis of rheumatology and COVID-19 researches.
    Pasin O; Pasin T
    Clin Rheumatol; 2021 Nov; 40(11):4735-4740. PubMed ID: 34215906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pseudoscience at the expense of rheumatic disease patients during the Coronavirus disease 2019 pandemic.
    Akkoc N
    Clin Exp Rheumatol; 2021; 39 Suppl 128(1):5-7. PubMed ID: 32662406
    [No Abstract]   [Full Text] [Related]  

  • 56. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
    Dejaco C; Bijlsma JW; Buttgereit F
    Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
    [No Abstract]   [Full Text] [Related]  

  • 57. Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic.
    Lauper K; Bijlsma JWJ; Burmester GR
    Ann Rheum Dis; 2021 Jan; 80(1):26-30. PubMed ID: 33055081
    [No Abstract]   [Full Text] [Related]  

  • 58. Implementation of podiatry telephone appointments for people with rheumatic and musculoskeletal diseases.
    Palmer JL; Siddle HJ; Redmond AC; Alcacer-Pitarch B
    J Foot Ankle Res; 2021 Jan; 14(1):4. PubMed ID: 33413562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
    Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
    Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic.
    Masini F; Gjeloshi K; Ferrara R; Pinotti E; Cuomo G
    Rheumatol Int; 2020 Sep; 40(9):1537-1538. PubMed ID: 32666135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.